Clinical Trials Directory

Trials / Completed

CompletedNCT06248788

Salivary Immunoglobulin A (sIgA) Normal Range Study

Study to Survey the Normal Range of Salivary Immunoglobulin A (sIgA) Levels Measured by a Point of Care Device in Healthy Adult Women and Men

Status
Completed
Phase
Study type
Observational
Enrollment
47 (actual)
Sponsor
4Life Research, LLC · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Salivary Immunoglobulin A (sIgA) is a marker of immune system activity. Typically, sIgA is determined by an ELISA test in which samples have to be sent to a specialized laboratory for testing. Investigators have developed a new instrument that is small, portable, and easy to use. This instrument is available for consumers to purchase and test their own sIgA at home.

Conditions

Interventions

TypeNameDescription
DEVICEPoC DevicePoC Device for Testing Salivary IgA

Timeline

Start date
2017-06-19
Primary completion
2018-01-20
Completion
2018-01-20
First posted
2024-02-08
Last updated
2024-02-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06248788. Inclusion in this directory is not an endorsement.